eKare enhances its offering with the launch of Remote Monitoring and new Smartphone capabilities
The inSight® 3D imaging and wound measurement system incorporates the latest achievements in artificial intelligence and deep learning, giving clinicians the power to make data-driven decisions to effectively treat patients. This month eKare launches its new Remote Monitoring feature, which enables Clinicians to give appropriate patients access to a simplified version of inSight® via their smartphone, empowering selfcare and monitoring of their wounds remotely.
This is particularly relevant with the impact of more virtual working due to Covid-19. eKare is now working with organizations across the healthcare continuum around the globe to implement new digital pathways which enable increased patient engagement, quality of life and also deliver an efficiency saving. This alongside eKare’s launch of inSight® on Android later this month means that no matter what smartphone device you have, both clinicians and patients are able to use the inSight Wound Platform.
WINNERS – Wounds Today “Best Use of Digital Technology” Award
eKare’s inSight® digital 3D imaging and wound measurement system has been selected as the winner of the Wounds Today “Best Use of Digital Technology”. The Panel were looking for innovative and ground-breaking use of technology – whether that’s apps, websites, mobile technology, social media or something different.
Wound Care Today is the leading UK Wound Media company running Conferences, Journals and digital events. Ed Rusling CEO of Wounds today congratulated the team at eKare, “We think it’s a fantastic product and will become increasingly relevant in the years ahead in the UK and Globally.”
“To win the Award for our inSight technology is a fantastic achievement,” says Stephen Doades of eKare. “We look forward to supporting the UK with our technology and continue to bring innovative solutions to the NHS.”
For further information please visit our website www.ekare.ai or please contact us:
eKare UK T: 0330 133 0437
